Compared with the carvedilol group, patients prescribed propranolol were younger, less likely to suffer from congestive heart failure (CHF) or diabetes with chronic complications, and less likely to have a prescription for clopidogrel, ARBs, loop diuretics, spironolactone, statins, amiodarone, or insulin. The gene discussed is INS; the disease is congestive heart failure.